Drugs / 122-0551 Foam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02367911 | Jan → Aug 2015 | psoriasis | Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 122-0551 Foam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02367911 ↗ |
| Route | Topical | “122-0551 Foam, topically applied twice daily for two weeks” NCT02367911 ↗ |